Table 3.
Risk of various clinical outcomes up to 5 years in all patients.
| Outcomes | Incidence of event at 5 years [ n (%)] | Crude HR (95% CI) | P-value | Adjusted HR (95% CI) | P-value | |
|---|---|---|---|---|---|---|
| Diabetes (n = 316) | Non-diabetes (n = 403) | |||||
| All-cause mortality | 16 (5.1) | 7 (1.7) | 2.97 (1.22–7.23) | 0.016 | 2.37 (0.94–5.98) | 0.068 |
| Cardiac death | 7 (2.2) | 4 (1.0) | 2.26 (0.66–7.73) | 0.192 | 1.17 (0.30–4.60) | 0.822 |
| MI | 23 (7.3) | 32 (7.9) | 0.93 (0.54–1.59) | 0.790 | 0.91 (0.52–1.59) | 0.744 |
| Stroke | 11 (3.5) | 11 (2.7) | 1.30 (0.56–2.99) | 0.541 | 1.00 (0.43–2.35) | 1.000 |
| TVR | 64 (20.3) | 67 (16.6) | 1.25 (0.89–1.76) | 0.204 | 1.28 (0.90–1.81) | 0.169 |
| MACCE | 90 (28.5) | 85 (21.1) | 1.40 (1.04–1.88) | 0.028 | 1.47 (1.08–2.00) | 0.013 |
MI, myocardial infarction; TVR, target-vessel revascularization; MACCE, major adverse cardiac and cerebrovascular events.